Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2002

View Archived Issues

Inhibition of breast cancer cell growth in vitro with c-myc oligonucleotides and ICI-182780

Novel anticancer therapy: paclitaxel combined with an MEK inhibitor enhances apoptosis

Topical liposomal tacrolimus effective in murine model of immune-mediated skin disorders

Keratinocytes from papillomavirus-infected skin express antimicrobial peptide

Antiangiogenic effects of zoledronic acid demonstrated in vitro and in vivo

Novel HIV protease inhibitors identified at Pharmacor

Toagosei presents novel ammonium salts with antibacterial, antifungal and antiprotozoal activity

Novel CRF antagonists and their use in depression, anxiety, etc.

cGMP-selective PDE inhibitors under study at Bayer

New zinc complexes with dual activity as insulin mimetics and antihypertensive agents

Novel PDE5 inhibitors developed by Lilly Icos researchers

Japan Energy describes TNF-alpha and IL-6 production inhibitors

Memory-improving compounds covered by Zenyaku Kogyo patent

Bayer Diagnostics completes Visible Genetics acquisition

ActivBiotics and DepoMed to develop rifalazil for gastrointestinal bacterial infections

New class of compounds for drug-resistant HIV discovered at Pharmacor

Additional data reported on the efficacy and safety of aripiprazole in schizophrenia

Inhibitors of two-component regulatory system as potentially novel antibacterial agents

Ras inhibitor FTS reduces autoantibodies in animal models of APS

EGFR-targeted MAb improves response to radiotherapy in SCCHN

Doxovir 1% eliminates HPV11 from foreskin grafts in mouse model

Epicyte receives grant for production of HIV hybrid antibodies

FluINsure challenge study cleared in U.K.

Long-term safety data for RG-1068

German approval for Ezetrol

Columbia and Ardana enter European marketing partnership for Striant

Canadian IND cleared for Generex's buccal fentanyl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...